[CLINICAL EXPERIENCES WITH VALIUM ROCHE, A NEW BENZODIAZEPINE DERIVATIVE].
D000987:Antisocial Personality Disorder; D001007:Anxiety; D001008:Anxiety Disorders; D001342:Autonomic Nervous System Diseases; D001569:Benzodiazepines; D035843:Biomedical Research; D003863:Depression; D003975:Diazepam; D004827:Epilepsy; D006801:Humans; D007046:Hysteria; D008607:Intellectual Disability; D001523:Mental Disorders; D009497:Neurotic Disorders; D011604:Psychoses, Alcoholic; D011618:Psychotic Disorders; D012559:Schizophrenia; D007319:Sleep Initiation and Maintenance Disorders
D001569:Benzodiazepines; D003975:Diazepam
ANXIETY; AUTONOMIC DYSFUNCTION; CLINICAL RESEARCH; DEPRESSION; DIAZEPAM; EPILEPSY; HYSTERIA; IDIOCY; INSOMNIA; NEUROSES; PSYCHOSES, ALCOHOLIC; SCHIZOPHRENIA; SOCIOPATHIC PERSONALITY
KLINISCHE ERFAHRUNGEN MIT VALIUM ROCHE, EINEM NEUEN BENZODIAZEPINDERIVAT.